Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange
- PMID: 25413611
- DOI: 10.1002/jca.21371
Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange
Abstract
Drug associated thrombotic microangiopathy (TMA) is a rare event causing thrombocytopenia, microangiopathic anemia, renal failure, and neurologic abnormalities. Here, we present a case of TMA that occurred during the first cycle of treatment with carfilzomib for relapsed multiple myeloma.
Keywords: carfilzomib; multiple myeloma; plasma exchange; thrombotic microangiopathy.
© 2014 Wiley Periodicals, Inc.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
